More women adopt thinner ThinPrep Pap test for cancer screen
In three years since federal approval, the ThinPrep Pap Test has grown to about 13 percent of U S Pap smears, with forecasts reaching 20 percent next year. Cytyc touts higher accuracy and fewer repeat tests, while insurers weigh cost and coverage amid debate over benefits.
MENTIONED IN THIS ARTICLE
New York
United States
Kenneth Noller
University of Massachusetts Medical School
ThinPrep
Cytyc
Roxborough
Mass
Blue Cross
Blue Shield
Kaiser Permanente
Aetna
Thomas Gunderson
US Bancorp
Piper Jaffray
Jennifer Bryner
Lancaster
American Cancer Society
George Papanicolaou
National Institutes of Health
American College of Obstetrics and Gynecology
Patrick Sullivan
Also Mentioned on This Page
Cervix
Cytyc Corporation
AP Research
Cervical
Pulding Is
East
Bidgs
Rvs
China
Odessa
Mortgage Funding Network, Inc
West
Ben White
Austin, Tx
Treasury Arm
Pelee
Music City Mall
Live Oak Plaza
One Energy Square
West County Plaza
Mon
Te Om
Eureka U
Eureka
Ig Lane
Cherry Entertainment
GE Electric
Zenith
Palace
Dresser & Mirror
N. Andrews Hwy
Lacks.com